Michael Breus
Michael Breus is a clinical psychologist and a Diplomate of the American Board of Sleep Medicine. His published research focuses on sleep quality, health interventions, and wellness technology, including the use of transcutaneous vibratory stimulation devices, mattress designs, and subscriber engagement with meditation apps.
76 claims checked on air: 9 context 14 contradicted 8 overstated 31 supported 14 unverified
What they said on air - supported
A person's ability to understand complicated concepts improves when they are more in line with their chronotype.
"There's even data to show that your ability to understand complicated concepts improves when you're more in line with your chronotype." (said at 0:00:59)
A substantial body of chronobiology and cognitive psychology literature documents the 'synchrony effect,' wherein cognitive performance—particularly on demanding, analytical, and fluid reasoning tasks—improves when testing occurs at times of day aligned with an individual's circadian preference (chronotype). Review evidence confirms that aligning performance with peak circadian arousal benefits complex executive tasks, memory, and analytical problem-solving.
- supports: For Whom (and When) the Time Bell Tolls: Chronotypes and the Synchrony Effect. (Perspectives on psychological science : a journal of the Association for Psychological Science 2023) · cited 24x in the literature
"Across studies of attention and memory and a range of allied areas, including academic achievement, judgment and decision-making, and neuropsychological assessment, optimal outcomes are found when performance times align with peaks in circadian arousal, a finding known as the synchrony effect . The benefits of performing in synchrony with one's chronotype (and the costs of not doing so) are most robust for individuals with strong morning or evening chronotypes and for tasks that require effortful, analytical processing or the suppression of distracting information." (abstract, passage verified)
pubmedfull study (doi) - supports: Chronotype and synchrony effects in human cognitive performance: A systematic review. (Chronobiology international 2025) · cited 12x in the literature
"There was evidence from 29 (45.31%) of 64 studies involving adults aged 18-45 y of a synchrony effect (i.e. superior performance at optimal ToD) in morning and/or evening types, mostly in attention, inhibition, and memory. In older adults, there was evidence of a synchrony effect from 10 (83.33%) of 12 studies, especially on tasks involving fluid abilities." (abstract, results, passage verified)
pubmedfull study (doi)
It takes approximately 25 to 30 minutes for ingested caffeine to be absorbed and digested before it kicks in.
"It has to go down, has to get absorbed, has to be digested. And so, while all that's going on, which takes approximately 25 to 30 minutes" (said at 0:11:32)
Oral caffeine is rapidly and virtually completely absorbed from the gastrointestinal tract, with noticeable physiological effects and rising plasma levels occurring within approximately 15 to 45 minutes of ingestion (typically reaching peak plasma concentrations within 30 to 60 minutes). The statement that it takes approximately 25 to 30 minutes to be absorbed and kick in is well-supported by pharmacokinetic literature.
At around 10:30 to 11:30 PM, circulating levels of estrogen, testosterone, progesterone, adrenaline, and cortisol are low while melatonin levels are high.
"In order to have successful sex, you want to have estrogen, testosterone, progesterone, adrenaline, and cortisol all to be high, and melatonin to be low. What do you think your hormone profile looks like at 10:30 at night? It's literally the opposite, right? Melatonin is high, and all those other things are low." (said at 0:15:48)
Human circadian physiology shows that around late evening (10:30 to 11:30 PM), pineal melatonin secretion increases significantly as part of the dim-light melatonin onset. Concurrently, major wake-promoting and anabolic hormones such as cortisol and testosterone reach their diurnal nadir (lowest daily baseline levels) in the late evening before sleep, while sympathetic adrenal output (adrenaline) drops during rest. Female sex steroids (estrogen and progesterone) are primarily governed by the monthly menstrual cycle rather than strong diurnal rhythms, but they do not exhibit nocturnal spikes. Thus, the speaker's description of a late-night hormone profile characterized by high melatonin alongside low levels of cortisol, testosterone, and adrenaline reflects established diurnal endocrinology.
- supports: Effect of shift work on the night-time secretory patterns of melatonin, prolactin, cortiso… (European journal of applied physiology and occupational physiology 1990) · cited 149x in the literature
"Serum cortisol presented a decreased rhythm amplitude together with higher concentrations at 0000 hours in shift workers." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Changes in the diurnal rhythms of cortisol, melatonin, and testosterone after 2, 4, and 7 … (Chronobiology international 2016) · cited 55x in the literature
"The diurnal rhythms of melatonin, cortisol, and testosterone were all affected differently by an increasing number of consecutive night shifts" (abstract, results, passage verified)
pubmedfull study (doi)
Intermediate chronotypes (bears) make up between 50% and 55% of the population.
"9:00 to 5:00 is perfect for a bear and they make up between 50 and 55% of the population. So literally one out of two people is a bear." (said at 0:21:34)
Epidemiological studies using standardized circadian typology assessments (such as the Morningness-Eveningness Questionnaire or Munich ChronoType Questionnaire) demonstrate that chronotype is approximately normally distributed in the general population. When categorized into three main profiles (morning, intermediate/neither, and evening), the intermediate chronotype (popularized in some frameworks as the "bear" chronotype) typically comprises roughly 45% to 55% of the adult population.
Chronotypes shift across the human lifespan, moving from early in young childhood to peak eveningness in adolescence, stabilizing around ages 23 to 24, and shifting earlier again around the mid-50s.
"When you're an itty-bitty baby, you're a lion. You go to bed really early. You wake up really early, right? Then you're a toddler, right? And like in grammar school, you're a bear, you're going to bed around 7:30, you're waking up around 7:30. Then adolescence hits, right? What do you want to do? Stay up until midnight and sleep until 2:00, right? You become a wolf. Then at about 23, 24, your chronotype has tendency to set into one of those three or four things, and then you stay there for an extended period of time like 25, 30 years, until you hit my age. So, I'm going to be 58 soon, and right when you hit in the mid-50s, what we see is melatonin production can either slow down or get earlier." (said at 0:24:52)
Published population-level chronobiology research supports the general trajectory described by the speaker. In large epidemiological surveys measuring chronotype (such as mid-sleep timing on work-free days), sleep-wake patterns are earlier in young childhood, progressively shift later during adolescence (reaching peak eveningness around ages 19-24 depending on sex and population cohorts), and then gradually shift earlier across adulthood and mid-to-late life. While the speaker uses popular metaphorical archetypes (lion, bear, wolf) and informal approximations, the physiological pattern of childhood morningness, adolescent eveningness peaking in the early twenties, and progressive advance with aging/mid-life is well established in observational and cross-sectional data.
- supports: Chronotypes in the US - Influence of age and sex. (PloS one 2017) · cited 514x in the literature
"The distribution's mean value is systematically different with age, shifting later during adolescence, showing a peak in 'lateness' at ~19 years, and shifting earlier thereafter. Men are typically later chronotypes than women before 40, but earlier types after 40. The greatest differences are observed between 15 and 25 for both sexes, equaling more than 50% of the total chronotype difference across all age groups." (abstract, results, passage verified)
pubmedfull study (doi)
The ideal amount of sleep for adults is between 7 and 9 hours per night.
"The truth of the matter is somewhere between 7 and 9 hours really is kind of the amount that people should be looking for" (said at 0:30:50)
Major sleep health guidelines support 7 to 9 hours of sleep per night as the recommended duration for healthy adults. In formal multidisciplinary consensus recommendations by the National Sleep Foundation using the RAND/UCLA Appropriateness Method, 7 to 9 hours was designated as the recommended sleep duration range for young adults (aged 18–25) and adults (aged 26–64), with 7 to 8 hours recommended for older adults (aged 65+).
Getting less than 6 hours of sleep significantly impairs driving ability and machinery operation.
"When somebody gets less than 6 hours' sleep, their driving is off, and so you can't operate machinery." (said at 0:31:08)
Large prospective cohort studies demonstrate that sleeping 6 or fewer hours per night significantly impairs driving safety and elevates motor vehicle crash risk. In a community cohort of 3,201 adults, sleeping 6 hours per night was associated with a 33% increased crash risk compared to sleeping 7 to 8 hours. Similarly, the DRIVE prospective cohort study of nearly 20,000 young drivers found that individuals averaging 6 or fewer hours of sleep per night had a 21% higher risk of motor vehicle crash (RR 1.21, 95% CI 1.04–1.41) compared to those sleeping longer.
During slow-wave deep sleep, the glymphatic system clears accumulated toxic proteins from the brain that are associated with Alzheimer's disease.
"during that particular stage of sleep, there's something called the glymphatic system that comes in and scoops out these proteins that have a tendency to accumulate in your brain. And when proteins accumulate in your brain, they wrap around the nerves, and that's called Alzheimer's disease." (said at 0:35:12)
Preclinical and clinical neuroimaging studies confirm that the glymphatic system—a brain-wide perivascular pathway for cerebrospinal fluid-interstitial fluid exchange—shows peak activity during slow-wave non-rapid eye movement (NREM) sleep. During this phase, convective fluid flux facilitates the clearance of metabolic waste products and neurotoxic proteins, particularly amyloid-β and tau, which are pathognomonic markers of Alzheimer's disease. While initial mechanistic demonstrations were established in rodent models, subsequent human imaging and physiological studies consistently identify slow-wave activity as a primary driver of glymphatic waste clearance.
- supports: Sleep drives metabolite clearance from the adult brain. (Science (New York, N.Y.) 2013) · cited 5433x in the literature
"Using real-time assessments of tetramethylammonium diffusion and two-photon imaging in live mice, we show that natural sleep or anesthesia are associated with a 60% increase in the interstitial space, resulting in a striking increase in convective exchange of cerebrospinal fluid with interstitial fluid. In turn, convective fluxes of interstitial fluid increased the rate of β-amyloid clearance during sleep." (abstract, results, passage verified)
pubmedfull study (doi) - supports: The glymphatic system and its involvement in disorders of the nervous system. (Medicina clinica 2021) · cited 9x in the literature
"Aquaporin-4, located in astrocyte feet attached to the paravascular spaces, plays a key role in the clearance of waste molecules, such as beta-amyloid or tau proteins. The activity of this system is increased during sleep, mainly in the slow wave phase and while sleeping on one side, and with exercise, and is reduced with aging." (abstract, passage verified)
pubmedfull study (doi) - supports: Targeting Sleep Physiology to Modulate Glymphatic Brain Clearance. (Physiology (Bethesda, Md.) 2025) · cited 48x in the literature
"A particular focus is placed on strategies to enhance slow-wave activity during nonrapid eye movement sleep as a driver of glymphatic brain clearance. Overall, this review provides a comprehensive overview on the potential preventative and therapeutic applications of sleep interventions in combating neurodegeneration, cognitive decline, and dementia." (abstract, passage verified)
pubmedfull study (doi)
Alcohol consumption flushes magnesium and water from the human body.
"Because remember, wine pulls both magnesium and most water out of your system because it makes you have to go pee." (said at 0:36:25)
Acute alcohol intake acts as a renal diuretic and directly increases urinary excretion of both water and magnesium. Human experimental studies show that alcohol consumption leads to a prompt, dose-dependent increase in urinary magnesium loss (hypermagnesuria) up to two to three times baseline levels, alongside fluid loss.
- supports: The dose-dependency of alcohol-induced hypoparathyroidism, hypercalciuria, and hypermagnes… (Bone and mineral 1992) · cited 43x in the literature
"We conclude that in nonalcoholic subjects acute alcohol intake induces hypoparathyroidism, hypercalciuria, and hypermagnesuria, the latter two being dose-dependent." (abstract, conclusions, passage verified)
pubmedfull study (doi) - supports: Magnesium homeostasis and alcohol consumption. (Magnesium research 2008) · cited 62x in the literature
"As a result of this loss, serum magnesium tends to decrease while urinary magnesium excretion increases 2-3 fold." (abstract, results, passage verified)
pubmed - supports: Magnesium deficiency and alcohol intake: mechanisms, clinical significance and possible re… (Journal of the American College of Nutrition 1994) · cited 56x in the literature
"First, alcohol acts acutely as a Mg diuretic, causing a prompt, vigorous increase in the urinary excretion of this metal along with that of certain other electrolytes." (abstract, results, passage verified)
pubmedfull study (doi)
Normal sleep onset latency is approximately 12 to 15 minutes.
"It should take you about 12 to 15 minutes to actually fall asleep, okay?" (said at 0:41:05)
Normative polysomnographic and sleep quality guidelines indicate that normal sleep onset latency in healthy adults typically averages around 10 to 20 minutes (commonly cited as ~15 minutes). The National Sleep Foundation's consensus panel on sleep quality indicators considers a sleep onset latency of ≤15 minutes (or ≤30 minutes across broad age groups) to be an appropriate indicator of good sleep quality in healthy individuals, whereas very short latencies (<5 minutes) indicate excessive sleepiness and prolonged latencies (>30 minutes) reflect sleep-onset insomnia.
- supports: Meta-analysis of quantitative sleep parameters from childhood to old age in healthy indivi… (Sleep 2004) · cited 3365x in the literature
"The research reports included in this meta-analysis met the following criteria: (1) included nonclinical participants aged 5 years or older; (2) included measures of sleep characteristics by "all night" polysomnography or actigraphy on sleep latency, sleep efficiency, total sleep time" (abstract, methods, passage verified)
pubmedfull study (doi) - supports: National Sleep Foundation's sleep quality recommendations: first report. (Sleep health 2017) · cited 1317x in the literature
"For most of the sleep continuity variables (sleep latency, number of awakenings >5minutes, wake after sleep onset, and sleep efficiency), the panel members agreed that these measures were appropriate indicators of good sleep quality across the life-span." (abstract, results, passage verified)
pubmedfull study (doi)
Mild obstructive sleep apnea is clinically categorized as having between 5 and 15 breathing cessation events per hour of sleep.
"somebody with sleep apnea could have between 5 and 15 times per hour that they stop breathing and that's mild." (said at 1:03:30)
Standard clinical classification defines mild obstructive sleep apnea (OSA) as an Apnea-Hypopnea Index (AHI) of 5 to 15 respiratory disruption events per hour of sleep. An index below 5 is considered normal, 15 to 30 is classified as moderate OSA, and greater than 30 is classified as severe OSA.
Between 18% and 20% of the US population has undiagnosed obstructive sleep apnea.
"And the percentage of people in the US that have undiagnosed sleep apnea is pretty big. It's like somewhere between I think like 18 to 20%." (said at 1:04:00)
Epidemiological modelling and population-based prevalence studies in the United States support the claim. Total obstructive sleep apnea (OSA, defined as an apnea-hypopnea index ≥5 events/hour) prevalence among US adults is estimated at approximately 26% to 34% (e.g., 32.4% among adults aged 20 and older in contemporary estimates, and 34.3% among adults aged 30–69). Studies evaluating underdiagnosis consistently demonstrate that the vast majority (approximately 70% to >80%) of individuals with OSA in community samples remain undiagnosed, which corresponds to roughly 18% to 26% of the general adult US population having undiagnosed OSA.
- supports: Projecting the 30-year burden of obstructive sleep apnoea in the USA: a prospective modell… (The Lancet. Respiratory medicine 2025) · cited 30x in the literature
"By 2050, the prevalence of obstructive sleep apnoea (apnoea-hypopnoea index ≥5/h) is expected to show a relative increase of 34·7%, from 34·3% (95% uncertainty interval [UI] 34·0-34·4) to 46·2% (46·0-46·4), resulting in 76·6 million cases." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Unmasking obstructive sleep apnea: Estimated prevalence and impact in the United States. (Respiratory medicine 2025) · cited 42x in the literature
"A total of 83.7 million adults (aged 20 years and older) were estimated to be living with OSA in the US in 2024, of whom 49,459,041 (59%) were males and 34,257,378 (41%) females. This translates to 32.4% overall prevalence in the US among adults aged 20 years and older, with 39.1% among males and 26.0% in females, adjusting for obesity." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Obstructive sleep apnea underdiagnosis: Prevalence and correlates from the Sleep Health an… (Sleep advances : a journal of the Sleep Research Society 2026)
"In this sample with AHI ≥ 15/h, 81.4% had undiagnosed OSA (85.5% among the Hispanic participants of Mexican descent, 77.5% among the non-Hispanic white participants, not statistically significant difference)." (abstract, results, passage verified)
pubmedfull study (doi)
Women with obstructive sleep apnea tend to present differently than men, exhibiting less snoring, more frequent awakenings, and a higher prevalence of morning headaches.
"women don't have a tendency to have as much snoring as men do. Women have a tendency to have more arousals where they wake up constantly. Women have a tendency to report headaches in the morning, more so than men do. So, it's actually different types of symptoms for women versus men when it comes to sleep apnea." (said at 1:07:50)
Multiple large clinical cohort studies consistently demonstrate sex differences in the clinical presentation of obstructive sleep apnea (OSA). Women with OSA are less likely than men to report classic symptoms such as loud or habitual snoring and witnessed apneas, and are significantly more likely to report morning headaches, insomnia, nocturnal awakenings/wakefulness after sleep onset, and fatigue.
- supports: The influence of gender on symptoms associated with obstructive sleep apnea. (Sleep & breathing = Schlaf & Atmung 2018) · cited 83x in the literature
"Women with OSA were more likely to report tiredness, initial insomnia, and morning headaches, and less likely to complain of typical OSA symptoms (snoring, apneas) than men." (abstract, conclusions, passage verified)
pubmedfull study (doi) - supports: Gender differences in clinical manifestations and polysomnographic findings in Chinese pat… (Sleep & breathing = Schlaf & Atmung 2020) · cited 32x in the literature
"Women more commonly presented with insomnia (70.3% vs. 40.3%, p < 0.001), poor sleep quality (58.3% vs. 40.7%, p < 0.001), and headache on awakening (23.1% vs. 13.8%, p < 0.01) than men, while men more frequently reported habitual snoring (69.0% vs. 52.1%, p < 0.001) compared with women." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Sex differences in clinical and polysomnographic features of obstructive sleep apnea: The … (Sleep medicine 2025) · cited 6x in the literature
"Loud snoring and witnessed apnea were more common in men than in women whereas women were more frequently presented with insomnia, headache, and mood changes." (abstract, results, passage verified)
pubmedfull study (doi)
The glymphatic system operates during deep sleep stages to clear metabolic waste proteins from the brain.
"The deeper stages of sleep is where that glymphatic system comes in and scoops out those proteins, and that's really probably one of those big causes for it." (said at 1:11:31)
Published experimental and translational literature supports the claim that the glymphatic system is predominantly active during sleep, particularly during slow-wave (deep) non-REM sleep, facilitating the clearance of metabolic waste products and neurotoxic proteins such as amyloid-beta and tau from the central nervous system. Seminal in vivo animal studies demonstrated that natural sleep expands the interstitial space by approximately 60%, significantly increasing cerebrospinal fluid influx and waste removal compared to the awake state. While mechanistic evidence in animal models is robust, human observational studies show some methodological heterogeneity, but the core biological function remains well-supported.
- supports: Sleep drives metabolite clearance from the adult brain. (Science (New York, N.Y.) 2013) · cited 5433x in the literature
"Using real-time assessments of tetramethylammonium diffusion and two-photon imaging in live mice, we show that natural sleep or anesthesia are associated with a 60% increase in the interstitial space, resulting in a striking increase in convective exchange of cerebrospinal fluid with interstitial fluid. In turn, convective fluxes of interstitial fluid increased the rate of β-amyloid clearance during sleep." (abstract, results, passage verified)
pubmedfull study (doi) - supports: The glymphatic system and its involvement in disorders of the nervous system. (Medicina clinica 2021) · cited 9x in the literature
"Aquaporin-4, located in astrocyte feet attached to the paravascular spaces, plays a key role in the clearance of waste molecules, such as beta-amyloid or tau proteins. The activity of this system is increased during sleep, mainly in the slow wave phase and while sleeping on one side, and with exercise, and is reduced with aging." (abstract, results, passage verified)
pubmedfull study (doi)
Clinical studies show melatonin at doses of 5 mg to 7 mg is effective for improving sleep in children with autism spectrum disorder.
"There is however one group of children where melatonin does work well, and that's in kids on the autism spectrum. We don't know exactly why, but or at least I don't, but there is data to suggest that at 5, 6, 7 mg, that that can be very helpful for them." (said at 1:22:55)
Multiple randomized controlled trials and clinical studies demonstrate that exogenous melatonin, at doses ranging from 1 mg to 10 mg (frequently starting at 2 mg and escalating to 5 mg or 6-7 mg), is effective at improving total sleep time, reducing sleep latency, and decreasing nighttime awakenings in children and adolescents with autism spectrum disorder (ASD).
A pivotal 13-week double-blind randomized controlled trial (Maras et al., 2017) evaluated pediatric prolonged-release melatonin at 2 mg escalated to 5 mg in 125 children with ASD or neurogenetic disorders. Compared to placebo, melatonin significantly increased night-time total sleep time by 57.5 minutes (versus 9.1 minutes for placebo) and reduced sleep latency by 39.6 minutes (versus 12.5 minutes for placebo). In its 52-week open-label extension (Gringras et al., 2018), dosing titrated between 2 mg, 5 mg, and 10 mg sustained these improvements over the long term with good safety and tolerability profiles.
Systematic reviews of pediatric clinical trials (e.g., Albalawi et al., 2020) confirm that melatonin across the 2 mg to 10 mg dose range produces statistically and clinically significant improvements in sleep latency and sleep duration compared to placebo in children with ASD.
- supports: Efficacy and Safety of Pediatric Prolonged-Release Melatonin for Insomnia in Children With… (Journal of the American Academy of Child and Adolescent Psychiatry 2017) · cited 311x in the literature
"A total of 125 children and adolescents (2-17.5 years of age; 96.8% ASD, 3.2% Smith-Magenis syndrome [SMS]) whose sleep failed to improve on behavioral intervention alone were randomized (1:1 ratio), double-blind, to receive PedPRM (2 mg escalated to 5 mg) or placebo for 13 weeks... participants slept on average 57.5 minutes longer at night with PedPRM compared to 9.14 minutes with placebo... Sleep latency (SL) decreased by 39.6 minutes on average with PedPRM and 12.5 minutes with placebo" (abstract, results, passage verified)
pubmedfull study (doi) - supports: Long-Term Efficacy and Safety of Pediatric Prolonged-Release Melatonin for Insomnia in Chi… (Journal of child and adolescent psychopharmacology 2018) · cited 177x in the literature
"Ninety-five subjects... received PedPRM (2/5 mg) according to the double-blind phase dose, for 39 weeks with optional dose adjustment (2, 5, or 10 mg/day) after the first 13 weeks. After 52 weeks of continuous treatment... subjects slept... 62.08... minutes longer... fell asleep 48.6... minutes faster... PedPRM, an easily swallowed formulation shown to be efficacious versus placebo, is an efficacious and safe option for long-term treatment" (abstract, results and conclusion)
pubmedfull study (doi) - supports: Perspective on Melatonin Use for Sleep Problems in Autism and Attention-Deficit Hyperactiv… (Cureus 2020) · cited 23x in the literature
"Melatonin is a well-tolerated and safe medication in the dose range of 2-10 mg/day in the child and adolescent population." (abstract, results, passage verified)
pubmedfull study (doi)
Poison control center data documented an approximate 600% increase in reports of pediatric melatonin overdoses and ingestions.
"The rise in children overdosing on sleep gummies is the fastest growing trend in poison control data. GUEST1: Yeah, I think it's like almost 600% increase or something crazy like that for kids who have gotten who've overdosed on melatonin within There was a study that came out maybe a year ago, year and a half ago. Showed like almost 600% increase in overdoses for kids." (said at 1:26:45)
A 2022 CDC Morbidity and Mortality Weekly Report (MMWR) analyzed pediatric melatonin ingestions reported to the National Poison Data System (NPDS) from 2012 to 2021. The study found that annual pediatric melatonin ingestions reported to poison control centers increased by 530% over the 10-year period (from 8,337 in 2012 to 52,563 in 2021), accounting for 4.9% of all pediatric ingestions in 2021 compared to 0.6% in 2012. This aligns closely with the speaker's description of an approximate 600% (or 'almost 600%') increase reported in poison control data.
Studies evaluating melatonin supplementation up to one year indicate that endogenous melatonin production resumes normally when supplementation stops.
"So, right now we have studies that lead out to about a year or so on melatonin and when you stop their melatonin production after they've been taking it for a year, their body seems to start back up no problem." (said at 1:33:20)
Clinical trial evidence directly supports the claim. In a prospective open-label trial evaluating prolonged-release melatonin (2 mg nightly) for 6 to 12 months in adults with insomnia, endogenous melatonin production was evaluated following discontinuation by measuring nocturnal urinary excretion of 6-sulfatoxymelatonin (the primary melatonin metabolite). Discontinuation after up to 12 months of continuous use was not associated with suppression of endogenous melatonin production, rebound insomnia, or withdrawal symptoms.
When men take exogenous testosterone, their bodies stop producing endogenous testosterone.
"So, with testosterone, we know that when men start taking testosterone, their body actually stops producing it." (said at 1:33:35)
The speaker correctly stated that when men receive exogenous testosterone, their bodies stop (or significantly reduce) endogenous testosterone production. Administration of exogenous testosterone exerts negative feedback on the hypothalamic-pituitary-gonadal (HPG) axis, inhibiting the secretion of gonadotropins (luteinizing hormone and follicle-stimulating hormone) and suppressing testicular production of endogenous testosterone.
Valerian root reduces anxiety and is more effective for sleep when combined with hops.
"One of them is valerian, right? Valerian is probably the most studied. It's a root. It's called the valerian root, but to be clear, it's an anti-anxiety medication, right? So, what it is is it helps lower your level of anxiety. And that is the reason why it has a tendency to work. Interestingly, when you look at the data, it works better when combined with hops" (said at 1:36:00)
Evidence from clinical trials and meta-analyses supports the speaker's claim. A 2020 systematic review and meta-analysis found that valerian root extracts significantly reduce anxiety across multiple clinical trials and improve sleep quality. Furthermore, randomized controlled trials directly comparing valerian monotherapy against a fixed combination of valerian and hops (Humulus lupulus) demonstrated that while valerian alone did not significantly outperform placebo in reducing objective sleep latency, the valerian-hops combination achieved statistically significant reductions.
- supports: A randomized, double blind, placebo-controlled, prospective clinical study to demonstrate … (Phytotherapy research : PTR 2007) · cited 80x in the literature
"The fixed extract combination was significantly superior to the placebo in reducing the sleep latency whilst the single valerian extract failed to be superior to the placebo. The result underlined the plausibility for adding hops extract to the valerian extract." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Valerian Root in Treating Sleep Problems and Associated Disorders-A Systematic Review and … (Journal of evidence-based integrative medicine 2020) · cited 156x in the literature
"A total of 60 studies (n=6,894) were included in this review, and meta-analyses were performed to evaluate the effectiveness to improve subjective sleep quality (10 studies, n=1,065) and to reduce anxiety (8 studies, n=535). Results suggested that inconsistent outcomes were possibly due to the variable quality of herbal extracts and that more reliable effects could be expected from the whole root/rhizome. In addition, therapeutic benefits could be optimized when it was combined with appropriate herbal partners." (abstract, results, passage verified)
pubmedfull study (doi)
Gamma-aminobutyric acid (GABA) is an endogenous substance that functions as the primary inhibitory mechanism in the brain.
"it's called GABA, G-A-B-A, gamma-aminobutyric acid. So, this is a substance that your body makes. It's kind of the brakes of the brain, and you can buy it as a supplement." (said at 1:37:40)
Gamma-aminobutyric acid (GABA) is an endogenous amino acid synthesized in the body that serves as the principal inhibitory neurotransmitter across the central nervous system, acting to reduce neuronal excitability.
A person would need to drink almost half a gallon of warm milk to obtain enough tryptophan to induce sleep.
"Same holds true with milk. Tryptophan is the thing in warm milk that supposedly makes people sleepy, but once again, you'd have to drink almost a half a gallon of warm milk, which is kind of disgusting, in order to do it." (said at 1:39:20)
Clinical research shows that L-tryptophan effectively induces sleep and improves sleep parameters (such as reducing sleep latency and wakefulness after sleep onset) primarily at doses of 1 gram or greater. Cow's milk contains approximately 0.12 to 0.14 grams of L-tryptophan per 8-ounce (240 mL) serving. To reach a therapeutic 1-gram threshold of L-tryptophan purely from milk, an individual would need to consume roughly 7.5 to 8 cups, which equals approximately 0.47 to 0.5 gallons (nearly half a gallon).
Magnesium is involved in approximately 300 different biochemical functions in the human body.
"and then magnesium is used in about I think almost 300 different functions in the body, so it probably lets the body work more efficiently" (said at 1:41:09)
Magnesium is well established in biochemical and nutritional literature as an essential mineral and cofactor required for more than 300 distinct enzymatic reactions in the human body. These reactions include ATP-dependent energy metabolism, DNA and RNA synthesis, protein synthesis, neuromuscular conduction, and blood pressure regulation.
- supports: Magnesium and Human Health: Perspectives and Research Directions. (International journal of endocrinology 2018) · cited 465x in the literature
"It has several functions in the human body including its role as a cofactor for more than 300 enzymatic reactions." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Magnesium Matters: A Comprehensive Review of Its Vital Role in Health and Diseases. (Cureus 2024) · cited 66x in the literature
"It acts as a cofactor for more than 300 enzymatic reactions, facilitating the conversion of adenosine triphosphate (ATP) to adenosine diphosphate (ADP) for energy production." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Unlocking the Power of Magnesium: A Systematic Review and Meta-Analysis Regarding Its Role… (Antioxidants (Basel, Switzerland) 2025) · cited 26x in the literature
"Magnesium plays a crucial role in over 300 enzymatic reactions related to energy production, muscle contraction, and nerve function." (abstract, results, passage verified)
pubmedfull study (doi)
The majority of the magnesium in a banana is concentrated in the peel rather than the fruit pulp.
"Bananas are loaded with magnesium, but it turns out it's not the fruit, it's the peel itself." (said at 1:42:33)
Mineral composition analyses of fruits, including bananas, indicate that essential minerals such as magnesium are concentrated at higher levels in the peel compared to the edible pulp.
Cooling the body down enables it to transition into deeper stages of sleep.
"But if you can get your body to cool down, your body will go down and get into deeper stages of sleep. If you can stay cool versus bumping up and down all night long, let's say you're a woman in menopause, right? That becomes highly disruptive." (said at 1:49:46)
Published human sleep research supports the claim that cooling the body promotes deeper stages of sleep. Sleep onset and maintenance are closely coupled with thermoregulation and the circadian decline in core body temperature via peripheral heat dissipation. Controlled polysomnographic studies show that facilitating body heat loss (conductive body cooling) significantly increases slow-wave sleep (stage N3) and lowers heart rate, whereas heat exposure and elevated ambient or microclimate temperatures increase nocturnal awakenings and suppress slow-wave sleep.
Rewriting the ending of a recurring nightmare and reading it repeatedly before sleep alters the dream's content over a period of 7 to 10 days.
"And so, we change that in the dream in what you wrote down, and then we talk about it in therapy, and then right before bed you read this to yourself multiple times, and over 7 to 10 days you change the ending of the dream." (said at 1:55:55)
The speaker describes Imagery Rehearsal Therapy (IRT), a standardized cognitive-behavioral intervention for chronic and post-traumatic nightmares. In IRT, patients select a recurring nightmare, script a new positive or neutral ending/outcome while awake, and mentally rehearse or read the revised script daily. Randomized controlled trials and systematic reviews demonstrate that IRT significantly decreases nightmare frequency, alters nightmare content, and improves sleep quality and PTSD-related symptoms, often within short intervals of daily practice.
Sleeping in a new environment triggers the 'first night effect', which impairs sleep quality.
"every time you're in a different environment, you have something called the first night effect. So we see this with every human on earth. When you sleep in a new place for the first night, you never sleep well because it's new sounds, new sights, you know, new smells, all that stuff is new." (said at 2:00:32)
The 'first-night effect' (FNE) is a well-characterized neurobiological phenomenon in human sleep research. Polysomnography and neuroimaging studies show that sleeping in a novel or unfamiliar environment leads to measurable sleep disturbances, including prolonged sleep-onset latency, increased wakefulness after sleep onset, reduced slow-wave and REM sleep, and decreased sleep efficiency. Research demonstrates that this effect is mediated in part by interhemispheric asymmetry, wherein one brain hemisphere maintains a heightened state of vigilance (a 'night watch' mechanism) to monitor unfamiliar external sensory stimuli.
Sleeping on the stomach puts extra pressure on the lower back and can cause low back pain over time.
"The reason it's the worst position is when you're lying on your stomach right and the pillow is here, you're pushing on your back here and it causes what's called a splay, which is extra pressure on your lower back and that can give you low back pain over time." (said at 2:12:27)
The speaker claims that sleeping on the stomach (prone position) places increased pressure/strain on the lower back and can cause or increase low back pain over time.
A 2025 systematic review evaluating sleeping posture and low back pain found that prone sleeping increases low back pain risk due to lumbar strain and recommended avoiding the prone position to maintain spinal alignment and protect lower back health (PMID: 40338112). Additionally, a cross-sectional study of patients with chronic low back pain found that the prone position was the most commonly avoided sleeping position due to pain provocation (PMID: 38846227).
Sleeping on the right side causes gastric juices to leak and triggers gastroesophageal reflux disease, whereas sleeping on the left side avoids this.
"when you lie on your right side, all of your organs push down onto your stomach and it can leak some of those gastric juices and you end up with something called gastroesophageal reflux disease. So, the way I teach people is right is wrong. So, you don't sleep on your right side, you sleep on your left side if you can." (said at 2:12:57)
The claim is supported by physiological monitoring and clinical evidence. Studies using simultaneous sleep position and esophageal pH-impedance monitoring demonstrate that sleeping in the right lateral decubitus position is associated with significantly higher total acid exposure time and longer esophageal acid clearance times compared to the left lateral decubitus position. Anatomically, sleeping on the left side positions the gastroesophageal junction above the level of gastric contents (reducing liquid reflux exposure), whereas sleeping on the right side positions the junction below or level with liquid gastric contents, facilitating acid reflux and increasing transient lower esophageal sphincter relaxations (TLESRs) in patients with GERD.
- supports: Effect of lateral positioning on gastroesophageal reflux (GER) and underlying mechanisms i… (Neurogastroenterology and motility 2013) · cited 38x in the literature
"In GERD patients, TLESRs, GER, distension of proximal stomach, and gastric emptying are increased in RLP compared to LLP." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Associations Between Sleep Position and Nocturnal Gastroesophageal Reflux: A Study Using C… (The American journal of gastroenterology 2022) · cited 41x in the literature
"We observed a significantly shorter acid exposure time in the left (median 0.0%, P25-P75, 0.0%-3.0%), compared with the right lateral position (median 1.2%, 0.0%-7.5%, P = 0.022)" (abstract, results, passage verified)
pubmedfull study (doi) - supports: Left lateral decubitus sleeping position is associated with improved gastroesophageal refl… (World journal of clinical cases 2023) · cited 15x in the literature
"Two nonrandomized studies showed decreased AET and ACT in LLD sleep position in comparison to RLD (mean difference [MD] -2.03 [95%CI: -3.62 to -0.45]; -81.84 [95%CI: -127.48 to -36.20], respectively)" (abstract, results, passage verified)
pubmedfull study (doi)
Sleep follows the core body temperature cycle, and being in an environment that is too hot prevents falling asleep as core body temperature drops.
"sleep follows the core body temperature cycle, right? And so, as your core body temperature drops, you want your environment to drop with it because if it doesn't and the environment is too hot, you can't fall asleep." (said at 2:15:10)
The statement that sleep follows the core body temperature (CBT) cycle and is facilitated by cooling is well-supported by human and mammalian thermoregulatory physiology. Sleep onset normally coincides with a circadian-driven decrease in core body temperature, mediated by increased peripheral vasodilation (especially in the distal/glabrous skin) that dissipates heat to the surrounding environment. While an excessively hot environment impairs heat dissipation and can impede sleep onset or disrupt sleep continuity, mild warmth or comfortable microclimates prior to sleep can paradoxically facilitate peripheral vasodilation and subsequent core cooling.
Lavender, ylang-ylang, and vanilla aromatherapy have scientific evidence showing they improve sleep.
"Believe it or not, there are at least two scientifically rigorous studies that show that aromatherapy can actually be helpful for you. ... as you breathe in the aroma, two aromas have been shown to be helpful for sleep. One is lavender, surprise, surprise. The other is called ylang-ylang. That's one that's actually got some data on it, and I actually think I saw a study on vanilla." (said at 2:18:25)
Scientific evidence supports the claim that aromatherapy with lavender, ylang-ylang, and vanilla (or vanillin) can improve subjective or objective sleep parameters. Systematic reviews and meta-analyses show that lavender inhalation improves sleep quality across diverse populations. Randomized controlled trials have evaluated blends containing ylang-ylang and lavender, demonstrating significant improvements in global sleep quality scores compared to placebo. Additionally, laboratory polysomnography studies examining olfactory stimuli during sleep have demonstrated that presentation of odorants including lavender and vanillin enhances slow-wave delta activity and spindle power during non-rapid eye movement sleep without triggering cortical arousals.
- supports: Odors enhance slow-wave activity in non-rapid eye movement sleep. (Journal of neurophysiology 2016) · cited 72x in the literature
"Consistent with our hypotheses, we found that odor presentation during sleep enhanced the power of delta (0.5-4 Hz) and slow spindle (9-12 Hz) frequencies during non-rapid eye movement sleep. The increase was proportionate to odor duration." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Trial of Essential Oils to Improve Sleep for Patients in Cardiac Rehabilitation. (Journal of alternative and complementary medicine (New York, N.Y.) 2019) · cited 34x in the literature
"The mean PSQI global score was statistically significantly lower when receiving the intervention oil (mean = 4.9) than the mean PSQI global score when receiving placebo (mean = 8)... patient-reported sleep quality was significantly better when participants were exposed to essential oils (χ 2 = 4.5, p = 0.03) than when exposed to placebo." (abstract, results)
pubmedfull study (doi) - supports: A systematic literature review and meta-analysis of the clinical effects of aroma inhalati… (Medicine 2021) · cited 95x in the literature
"Meta-analysis of the 34 studies using the random-effects model revealed that the use of aromatherapy was highly effective in improving sleep problems such as insomnia, including quantitative and qualitative sleep effects (95% confidence interval [CI], effect sizes = 0.6491)... Among the single inhalation methods, the lavender inhalation effect was the greatest." (abstract, results, passage verified)
pubmedfull study (doi)
The human body dissipates heat faster through an unsocked foot because there is no hair on the bottom of the feet.
"you dissipate heat faster with an unsocked foot cuz there's no hair on the bottom of your feet. You ever notice when you're hot at night and you stick your foot out from under the covers, you instantly cool down and everything's okay?" (said at 2:19:31)
Human thermoregulatory physiology demonstrates that the glabrous (hairless) skin on the soles of the feet and palms of the hands is uniquely specialized for rapid heat dissipation. This rapid heat transfer occurs because glabrous skin contains specialized vascular structures called arteriovenous anastomoses (AVAs). AVAs are direct, low-resistance connections between small arteries and venous plexuses that can dilate to accommodate high rates of blood flow, acting as effective biological heat exchangers. Exposing the bare feet (such as sticking an unsocked foot out from bedding) allows high-volume convective and radiative heat loss, which facilitates the reduction in core body temperature necessary for thermoregulation and sleep onset.
Fact-checked episodes
Publications